|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred contract acquisition costs | |||||
| Non-cash lease expense | |||||
| Stock-based compensation | |||||
| Discount amortization on marketable securities | |||||
| Gain on sale of non-marketable equity investments | |||||
| Change in fair value of equity securities | |||||
| Release of valuation allowance | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Deferred contract acquisition costs | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued and other liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Capitalized internal-use software | |||||
| Purchases of marketable securities | |||||
| Sales of marketable securities | |||||
| Sale of non-marketable equity investments | |||||
| Maturities and redemptions of marketable securities | |||||
| Advances paid for business combination (Note 16) | |||||
| Business combination, net of cash acquired | |||||
| Net cash provided by investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from initial public offering, net of underwriting discounts | |||||
| Proceeds from issuance of common stock under employee stock purchase plan, net | |||||
| Proceeds from exercise of stock options | |||||
| Payment of withholding taxes on net share settlement of equity awards | |||||
| Payment of deferred offering costs | |||||
| Payment of acquisition-related liabilities | |||||
| Repurchase of common stock | |||||
| Net cash used in financing activities | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for taxes | |||||
| Non-cash investing and financing activities: | |||||
| Operating lease right-of-use assets obtained in exchange for operating lease obligations | |||||
| Stock-based compensation capitalized as internal-use software | |||||
| Accretion of redeemable convertible preferred stock | |||||
| Conversion of redeemable convertible preferred stock into common stock upon initial public offering | |||||
| Issuance of common stock and options in connection with acquisition | |||||
| Excise tax liability accrued for common stock repurchased | |||||
| Payables related to unsettled common stock repurchases | |||||
| Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current | |||||
| Restricted cash included in other assets | |||||
Loading...